These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7015516)

  • 1. Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy.
    Cocchetto DM; Cook L; Cato AE; Niedel JE
    Semin Thromb Hemost; 1981; 7(1):43-51. PubMed ID: 7015516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombotic thrombocytopenic purpura treated with prostacyclin. Apropos of 2 case reports].
    Guelpa G; Trono D; Audetat F; Hochstrasser D
    Schweiz Med Wochenschr; 1986 May; 116(19):647-51. PubMed ID: 3520815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ineffective epoprostenol therapy for thrombotic thrombocytopenic purpura.
    Johnson JE; Mills GM; Batson AG; Cato AE; Thornsvard CT
    JAMA; 1983 Dec; 250(22):3089-91. PubMed ID: 6358560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aggressive therapy in a case of Moschowitz syndrome].
    Trono D; Beris P; Parmeggiani L; Miescher PA
    Nouv Rev Fr Hematol (1978); 1984; 26(6):387-90. PubMed ID: 6396578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuccessful treatment of resistant thrombotic thrombocytopenic purpura with prostacyclin.
    Salvi F; Baraldi A; Allione B; Santi R; Inverardi D; Levis A
    Haematologica; 2000 Dec; 85(12):1329-30. PubMed ID: 11114144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin therapy of thrombotic thrombocytopenic purpura.
    Budd GT; Bukowski RM; Lucas FV; Cato AE; Cocchetto DM
    Lancet; 1980 Oct; 2(8200):915. PubMed ID: 6107563
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura. II. Principles of therapy and guidelines for management.
    Sills RH
    Am J Pediatr Hematol Oncol; 1984; 6(4):431-9. PubMed ID: 6398631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
    Fitzgerald GA; Maas RL; Stein R; Oates JA; Roberts LJ
    Ann Intern Med; 1981 Sep; 95(3):319-22. PubMed ID: 7023309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the determination of prostacyclin metabolism in the management of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Túri S; Beattie JT
    Orv Hetil; 1986 Jul; 127(29):1747-51. PubMed ID: 3526247
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombotic thrombocytopenic purpura (TTP) with a low level of apolipoprotein A-I (Apo A-I) which responded to combination of vincristine and beraprost].
    Kurosawa S; Nagata M; Saito T; Arai T; Momose T; Morio K; Mitsuhashi H
    Rinsho Ketsueki; 1994 Jul; 35(7):704-9. PubMed ID: 8065025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal prostacyclin-like activity in thrombotic thrombocytopenic purpura.
    Pini M; Manotti C; Quintavalla R; Dettori AG
    Thromb Haemost; 1981 Aug; 46(2):571. PubMed ID: 7029776
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostacyclin; clinical aspects].
    Sitsen JM; Nijkamp FP
    Ned Tijdschr Geneeskd; 1983 Jan; 127(5):199-206. PubMed ID: 6338406
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of thrombotic thrombocytopenic purpura by epoprostenol infusion.
    Payton CD; Belch JJ; Jones JM
    Lancet; 1985 Apr; 1(8434):927-8. PubMed ID: 2858768
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura.
    Bobbio-Pallavicini E; Porta C; Tacconi F; Gugliotta L; Centurioni R; Vianelli N; Billio A; Ascari E
    Haematologica; 1994; 79(5):429-37. PubMed ID: 7843629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous gamma-immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura.
    Finn NG; Wang JC; Hong KJ
    Arch Intern Med; 1987 Dec; 147(12):2165-7. PubMed ID: 3120657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beraprost sodium for refractory thrombotic thrombocytopenic purpura.
    Kurosawa S; Nagata M; Saito T
    Am J Hematol; 1995 Nov; 50(3):224. PubMed ID: 7485087
    [No Abstract]   [Full Text] [Related]  

  • 17. Nafazatrom in treatment of thrombotic thrombocytopenic purpura.
    Durrant ST; Joosten P; Gordon-Smith EC
    Lancet; 1985 Oct; 2(8459):842. PubMed ID: 2864567
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostacyclin-stabilising-factor deficiency in thrombotic thrombocytopenic purpura.
    Mikhailidis DP; Dandona P
    Lancet; 1982 Mar; 1(8273):678-9. PubMed ID: 6121983
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin deficiency in thrombotic thrombocytopenic purpura.
    Hensby CN; Lewis PJ; Hilgard P; Mufti GJ; Hows J; Webster J
    Lancet; 1979 Oct; 2(8145):748. PubMed ID: 90841
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin and thrombotic microangiopathy.
    Remuzzi G; Rossi E; Misiani R; Marchesi D; Mecca G; de Gaetano G; Donati MB
    Semin Thromb Hemost; 1980; 6(4):391-4. PubMed ID: 7013070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.